Tresiba is a basal insulin preparation containing insulin degludec. Its prolonged action provides a steady background supply of insulin, helping control blood glucose between meals and during periods without food.

The formulation is designed for once-daily administration in appropriate patients and may be combined with mealtime insulin or other diabetes medicines according to the treatment plan.

Brand: Tresiba

Active Ingredient: Insulin Degludec

Dosage Form: Injectable solution

Presentation: FlexTouch Pen

Pack Size: 1 pen

Category: Ultra-long-acting basal insulin

The prescribed dose should be individualized according to glucose readings and clinical requirements.